海升果汁(00359.HK):接獲聯交所復牌指引 繼續停牌
格隆匯5月18日丨海升果汁(00359.HK)發佈公吿,2022年5月13日,公司接獲聯交所的函件,當中載列以下恢復股份買賣的指引:(i)公佈《上市規則》要求的所有未完成的財務業績,並處理任何審計修改;(ii)證明公司遵守了規則13.24;(iii)證明公司是否遵守了規則3.05、3.10、3.21和3.28;以及(iv)向公司股東和其他投資者吿知市場所有重要信息,以評估公司的地位。
倘公司的狀況有變,聯交所可能會修改或補充已發出的復牌指引及╱或發出進一步指引。公司股份已於聯交所暫停買賣,並將維持暫停買賣直至公司達成復牌指引。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.